18 June 2013
Keywords: Eisai, AkaRx, MGI Pharma, AKR-501, Thrombosytopenia, M&A
Article | 21 December 2009
Japanese drug major Eisai has said it will initiate procedures to acquire New Jersey, USA-based AkaRx under a deal valuing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 December 2009
17 June 2013
© 2013 thepharmaletter.com